Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 26:39:100848.
doi: 10.1016/j.lanwpc.2023.100848. eCollection 2023 Oct.

Association between uric acid and risk of venous thromboembolism in East Asian populations: a cohort and Mendelian randomization study

Affiliations

Association between uric acid and risk of venous thromboembolism in East Asian populations: a cohort and Mendelian randomization study

Haoyi Weng et al. Lancet Reg Health West Pac. .

Abstract

Background: Serum uric acid (SUA) levels have been associated with an increased risk and recurrence of venous thromboembolism (VTE) in European populations, but the potential causal relationship remains unclear. Large-scale studies on the association between SUA and VTE in East Asian populations are lacking, despite the high prevalence of hyperuricemia in this region. To address this, we conducted a cohort analysis and a two-sample Mendelian randomization (MR) study in East Asian populations.

Methods: We collected data on VTE patients from the China Pulmonary Thromboembolism Registry Study (CURES) and compared them to controls obtained from the China Health and Retirement Longitudinal Survey (CHARLS). Propensity score matching (PSM) and cubic-spline models were applied to assess the effect of SUA on VTE risk while adjusting for multiple covariates. We also performed two-sample MR analyses to infer potential causality based on summary statistics from Genome-wide Association Studies (GWAS) of SUA and VTE in the East Asian population.

Findings: We found that the SUA levels were higher in VTE patients (317.95 mmol/L) compared to the general population (295.75 mmol/L), and SUA ≥ 325 mmol/L was associated with an increased risk of VTE recurrence (P-value = 0.0001). The univariable MR suggested a causal relationship between elevated SUA and higher VTE risk (Pinverse variance weighted < 0.05), and multivariable MR showed that elevated SUA levels continued to promote the development of VTE after adjusting for multiple covariates (Pmultivariable residual < 0.05). Sensitivity analyses produced similar results for these estimations.

Interpretation: Our study provides evidence supporting a robust positive association between SUA and VTE in the East Asian population, and MR analyses suggest that this association is likely to be causal. Our findings underscore the importance of monitoring SUA levels in VTE prevention and call for urgent action to address the growing burden of hyperuricemia in the Asia-Pacific region.

Funding: This research was funded by Beijing Nova Program (No. Z211100002121057), National Natural Science Foundation of China (No. 82100065 and No. 62350004), CAMS Innovation Fund for Medical Sciences (No. 2021-I2M-1-061 and No. 2021-1-I2M-001), Elite Medical Professionals project of China-Japan Friendship Hospital (No. ZRJY2021-QM12), National Key Research and Development Project (No. 2021YFF1201200 and No. 2022YFC3341004).

Keywords: Causal relationship; Mendelian randomization; Serum uric acid; Venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Study workflow chart. Association and causal effect of uric acid and venous thromboembolism.
Fig. 2
Fig. 2
Association between serum uric acid levels and venous thromboembolism recurrence risk. The solid black line is the estimated odds ratio, and the shaded blue area is the 95% confidence interval.
Fig. 3
Fig. 3
Two-sample Mendelian randomization reveals causal evidence for SUA on VTE. The forest plots illustrate the standardized beta (95% Confidence Interval) for each two-sample MR method.

References

    1. Khan F., Tritschler T., Kahn S.R., Rodger M.A. Venous thromboembolism. Lancet. 2021;398(10294):64–77. - PubMed
    1. Zhang Z., Lei J., Shao X., et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China. Chest. 2019;155(2):342–353. - PubMed
    1. Crous-Bou M., Harrington L.B., Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42(8):808–820. - PMC - PubMed
    1. Zhang Y., Zhang Z., Shu S., et al. The genetics of venous thromboembolism: a systematic review of thrombophilia families. J Thromb Thrombolysis. 2021;51(2):359–369. - PubMed
    1. Ghouse J., Tragante V., Ahlberg G., et al. Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism. Nat Genet. 2023;55(3):399–409. - PubMed

LinkOut - more resources